Ronald Nicholas Spaulding - 21 Aug 2024 Form 4 Insider Report for ATRION CORP

Role
Director
Signature
/s/Cindy Ferguson, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
21 Aug 2024
Net transactions value
-$1,375,635
Form type
4
Filing time
21 Aug 2024, 16:30:30 UTC
Previous filing
23 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRI common stock Disposed to Issuer $1,231,880 -2,678 -100% $460.00 0 21 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRI Deferred Stock Unit Disposed to Issuer $143,755 -313 -100% $460.00 0 21 Aug 2024 common stock 313 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash.